Bausch Health Companies (BHC) Set to Announce Earnings on Wednesday

Bausch Health Companies (TSE:BHC) is scheduled to be releasing its earnings data after the market closes on Wednesday, October 30th. Analysts expect Bausch Health Companies to post earnings of C$1.45 per share for the quarter.

Bausch Health Companies (TSE:BHC) last released its quarterly earnings data on Thursday, August 1st. The company reported C$1.22 earnings per share for the quarter, meeting the consensus estimate of C$1.22. Bausch Health Companies had a negative return on equity of 2,304.54% and a negative net margin of 5.12%. The company had revenue of C$3.29 billion for the quarter, compared to the consensus estimate of C$3.20 billion.

Bausch Health Companies Trading Down 0.8 %

TSE BHC opened at C$11.17 on Monday. The company has a market cap of C$4.10 billion, a price-to-earnings ratio of -6.38, a price-to-earnings-growth ratio of 0.21 and a beta of 0.77. Bausch Health Companies has a twelve month low of C$5.45 and a twelve month high of C$15.43. The business’s fifty day moving average is C$9.58 and its 200 day moving average is C$9.87. The company has a quick ratio of 0.58, a current ratio of 1.19 and a debt-to-equity ratio of 7,583.76.

Insiders Place Their Bets

In other news, Senior Officer Seana Lynne Carson sold 13,370 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of C$8.38, for a total value of C$112,087.40. Company insiders own 11.28% of the company’s stock.

Analysts Set New Price Targets

BHC has been the topic of several recent research reports. Raymond James raised Bausch Health Companies to a “hold” rating in a report on Wednesday, July 10th. Evercore ISI raised Bausch Health Companies to a “hold” rating in a report on Tuesday, October 15th.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.